国内首例，脑机接口！受试者“已可靠意念玩赛车游戏”

Group 1 - The core achievement of the company is the successful completion of the first long-term implantation clinical trial of an invasive brain-machine interface system in China at Huashan Hospital, Fudan University [1] - The invasive brain-machine interface system utilizes self-developed ultra-flexible neural electrode technology, with a diameter only 1/100 of a human hair, significantly improving biocompatibility compared to traditional rigid electrodes [1] - The clinical trial involved a participant who had been an amputee for many years, and post-surgery rehabilitation allowed the participant to control a computer mouse using brain signals, achieving a level comparable to that of a normal person after three weeks of training [1] Group 2 - The company received significant support, including being selected for the Ministry of Industry and Information Technology's "Future Industry Innovation Task" project and obtaining special funding for brain-machine interfaces from Shanghai for 2024 [2] - The company raised 350 million yuan in its Series B financing round, setting a record in the domestic implanted brain-machine interface sector, and has established the first medical-grade MEMS electrode processing platform in China [2] - The company aims to not only treat diseases but also expand human capabilities, with short-term focuses on motor function reconstruction and language decoding, and long-term plans to explore new forms of human-machine symbiosis by integrating large language models with embodied intelligent robots [2]